ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals Inc (RXRX)

6.03
-0.06
(-0.99%)
Closed 22 December 8:00AM
6.06
0.03
(0.50%)
After Hours: 11:58AM

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 13.68M12.13M11.02M10.53M10.89M13.79M14.42M26.08M
Operating Income -60.98M-69.87M-81.72M-99.55M-98.93M-96.34M-100.54M-98.35M
Pre Tax Income -57.49M-65.33M-76.73M-93.02M-97.06M-92.15M-98.06M-95.67M
Net Income -57.49M-65.33M-76.73M-93.02M-93M-91.37M-97.54M-95.84M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -61.16M-69.97M-81.66M-98.01M-101.55M-96.18M-100.77M-98.95M
EBITDA -54.77M-64.91M-76.23M-91.95M-91.38M-87.76M-93.71M-87.81M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 2.32M3.96M10.18M39.84M44.58M
Operating Income -62.44M-84.38M-182.78M-245.73M-350.06M
Pre Tax Income -61.88M-87.01M-186.48M-239.48M-332.13M
Net Income -61.88M-87.01M-186.48M-239.48M-328.07M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) -4.29-5.849-0.548-0.703-0.76
EBIT -62.43M-84.87M-182.77M-245.68M-351.15M
EBITDA -58.9M-79.3M-173.67M-231.14M-324.47M

Your Recent History

Delayed Upgrade Clock